Implementing routine screening for cannabis and other drug use disorders in primary care clinics
DAT- Implementing routine screening for cannabis and other drug use disorders in primary care: impact on diagnosis and treatment in a randomized pragmatic trial in 22 clinics
This study is looking at how adding simple checks for cannabis and other drug use during regular doctor visits can help more people get diagnosed and treated for substance use issues, making it easier for patients to find the support they need.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kaiser Foundation Research Institute NIH-funded |
| Lab location | 1 site (Oakland, UNITED STATES) |
| Project ID | NIH-10454855 on NIH RePORTER |
What this research studies
This research investigates how incorporating routine screening for cannabis and other drug use disorders into primary care can improve diagnosis and treatment outcomes. By conducting a randomized pragmatic trial across 22 clinics, the study aims to identify patients with substance use disorders who may otherwise go untreated. The approach focuses on integrating screening processes into regular healthcare visits, making it easier for patients to receive the help they need. The study will evaluate the effectiveness of this method in increasing the rates of diagnosis and treatment for substance use disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who visit primary care clinics and may be experiencing issues related to cannabis or other substance use disorders.
Not a fit: Patients who are not seeking care in primary care settings or who do not have substance use disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier identification and treatment of substance use disorders, improving overall patient health and reducing the societal impact of these conditions.
How similar studies have performed: Previous research has shown that integrating screening for substance use disorders in primary care can lead to improved treatment outcomes, suggesting that this approach has potential for success.
Where this research is happening
Oakland, UNITED STATES
- Kaiser Foundation Research Institute — Oakland, United States (Active)
Researchers
- Principal investigator: Angerhofer, Julie Elissa — Kaiser Foundation Research Institute
- Study coordinator: Angerhofer, Julie Elissa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.